Clinical trial
SOLX Titanium Sapphire Laser for Trabeculoplasty
NCT00145535 · SOLX, Inc., Industry · Completed
Key facts
| NCT number | NCT00145535 |
|---|---|
| Title | SOLX Titanium Sapphire Laser for Trabeculoplasty |
| Official title | SOLX Titanium Sapphire Laser for Trabeculoplasty |
| Lead sponsor | SOLX, Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Glaucoma, Open Angle |
| Intervention type | Device |
| Interventions | SOLX Titanium Sapphire Laser (TiSaLT), Argon Laser Trabeculoplasty (ALT) |
| Enrollment | 120 |
| Start date | May 1, 2004 |
| Primary completion | Jun 1, 2009 |
| Completion | Jun 1, 2009 |
| First posted | Sep 5, 2005 |
| Last update posted | Jan 29, 2010 |
| Countries | Canada, Israel, Spain, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: